Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:231
doi: 10.1161/CIRCULATIONAHA.107.183536
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2007;116:231.)
© 2007 American Heart Association, Inc.

Issue Highlights


*    PHOSPHODIESTERASE TYPE 5 IS HIGHLY EXPRESSED IN THE HYPERTROPHIED HUMAN RIGHT VENTRICLE, AND ACUTE INHIBITION OF PHOSPHODIESTERASE TYPE 5 IMPROVES CONTRACTILITY, by Nagendran et al.
up arrowTop
*PHOSPHODIESTERASE TYPE 5 IS...
down arrowMOLECULAR IMAGING OF...
down arrowNITINOL STENT IMPLANTATION...
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
The beneficial effects of phosphodiesterase type 5 (PDE5) inhibitors in patients with pulmonary hypertension have been attributed to the inhibitors’ vasodilatory and antiproliferative actions in the pulmonary vasculature. Nagendran et al found that PDE5, which is not expressed in normal myocardium, is upregulated in failing human right ventricular myocardium and also in hypertrophied right ventricle in a rat. PDE5 inhibition with sildenafil increased contractility in both a perfused heart preparation and in isolated cardiac myocytes from hypertrophied, but not normal, right ventricle. The investigators further relate this inotropic effect to cGMP-mediated inhibition of PDE3, which in turn increases cAMP levels. These unanticipated actions of PDE5 inhibition in the hypertrophied right ventricle may contribute to the clinical benefits of PDE5 inhibitors. See p 238 (editorial p 233).


*    MOLECULAR IMAGING OF INFLAMMATION IN ATHEROSCLEROSIS WITH TARGETED ULTRASOUND DETECTION OF VASCULAR CELL ADHESION MOLECULE-1, by Kaufmann et al.
up arrowTop
up arrowPHOSPHODIESTERASE TYPE 5 IS...
*MOLECULAR IMAGING OF...
down arrowNITINOL STENT IMPLANTATION...
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
The inflammatory component of atherosclerosis has proven difficult to evaluate in vivo. A noninvasive method of imaging the extent of vascular inflammation could help to define the initiation of atherosclerosis and potentially contribute to our understanding of plaque vulnerability. Kaufmann and colleagues use contrast-enhanced ultrasound to demonstrate that vascular cell adhesion molecule-1–targeted microbubbles attach to cultured endothelial cells and then further demonstrate attachment of these microbubbles to the aorta of apolipoprotein-E deficient mice. They also show the contrast-enhanced ultrasound videointensity correlates with the extent of vascular cell adhesion molecule-1–positive plaque formation. This provocative animal study is an exciting foray into this area of investigation and offers the potential to diagnose and track various stages of atherosclerosis with molecular imaging using contrast ultrasound. See p 276.


*    NITINOL STENT IMPLANTATION VERSUS PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN SUPERFICIAL FEMORAL ARTERY LESIONS UP TO 10 CM IN LENGTH: THE FEMORAL ARTERY STENTING TRIAL (FAST), by Krankenberg et al.
up arrowTop
up arrowPHOSPHODIESTERASE TYPE 5 IS...
up arrowMOLECULAR IMAGING OF...
*NITINOL STENT IMPLANTATION...
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
The interventional management of intermittent claudication due to superficial femoral artery disease remains controversial. Although percutaneous transluminal balloon angioplasty (PTA) is preferred by some, recent trials have suggested superior outcomes with stenting. This multicenter randomized trial compared the outcome of a single nitinol stent versus PTA in 244 patients with superficial femoral artery disease and chronic limb ischemia. Technical success was more common with stenting (95% versus 79%), resulting in a crossover rate of 11% in the PTA group. At 1 year, the primary end point of ultrasound-determined restenosis was not different between groups (38.6% versus 31.7%); likewise, target vessel revascularization was also not different. The trial did not demonstrate any differences between stent placement and PTA, although there was a trend toward an advantage of stenting in patients with diabetes and chronic occlusions. As the trial was sized to determine a 20% difference, larger trials would be needed to determine smaller differences. See p 285.

Visit http://circ.ahajournals.org:


*    Images in Cardiovascular Medicine
up arrowTop
up arrowPHOSPHODIESTERASE TYPE 5 IS...
up arrowMOLECULAR IMAGING OF...
up arrowNITINOL STENT IMPLANTATION...
*Images in Cardiovascular...
down arrowCorrespondence
 
Subacute Thrombotic Occlusion and Spontaneous Recanalization of the Right Coronary Artery After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Visualized by Coronary Angiography and Cardiac Magnetic Resonance Imaging. See p e78.

Multiple Coronary Artery–Left Ventricular Microfistulae and Spongy Myocardium: The Eagerly Awaited Link? See p e81.


Figure 15144
View larger version (52K):
[in this window]
[in a new window]

 


*    Correspondence
up arrowTop
up arrowPHOSPHODIESTERASE TYPE 5 IS...
up arrowMOLECULAR IMAGING OF...
up arrowNITINOL STENT IMPLANTATION...
up arrowImages in Cardiovascular...
*Correspondence
 
See p e85.


Related Articles:

Hypertrophied Right Hearts Get Two for the Price of One: Can Inhibiting Phosphodiesterase Type 5 Also Inhibit Phosphodiesterase Type 3?
David A. Kass
Circulation 2007 116: 233-235. [Full Text]

Subacute Thrombotic Occlusion and Spontaneous Recanalization of the Right Coronary Artery After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Visualized by Coronary Angiography and Cardiac Magnetic Resonance Imaging
Rainer Wessely, Rene M. Botnar, Marc Vorpahl, Markus Schwaiger, Albert Schömig, and Tareq Ibrahim
Circulation 2007 116: e78-e80. [Full Text]

Multiple Coronary Artery–Left Ventricle Microfistulae and Spongy Myocardium: The Eagerly Awaited Link?
Domenico Cartoni, Paolo Salvini, Rosario De Rosa, Andrea Cortese, Marco S. Nazzaro, and Pietro Tanzi
Circulation 2007 116: e81-e84. [Full Text]

Letter by Zitterman et al Regarding Article, "Calcium/Vitamin D Supplementation and Cardiovascular Events"
Armin Zittermann, Stefanie S. Schleithoff, and Reiner Koerfer
Circulation 2007 116: e85. [Full Text]

Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1
Beat A. Kaufmann, John M. Sanders, Christopher Davis, Aris Xie, Patrick Aldred, Ian J. Sarembock, and Jonathan R. Lindner
Circulation 2007 116: 276-284. [Abstract] [Full Text]

Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length: The Femoral Artery Stenting Trial (FAST)
Hans Krankenberg, Michael Schlüter, Hermann J. Steinkamp, Karlheinz Bürgelin, Dierk Scheinert, Karl-Ludwig Schulte, Erich Minar, Patrick Peeters, Marc Bosiers, Gunnar Tepe, Bernhard Reimers, Felix Mahler, Thilo Tübler, and Thomas Zeller
Circulation 2007 116: 285-292. [Abstract] [Full Text]




This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles